Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid
HIV-2 is thought to have entered the human population in the 1930s through cross-species transmission of SIV from sooty mangabeys in West Africa. Unlike HIV-1, HIV-2 has not led to a global pandemic, and recent data suggest that HIV-2 prevalence is declining in some West African states where it was...
Hlavní autoři: | Boswell, M, Rowland-Jones, S |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Wiley
2019
|
Podobné jednotky
-
TRIM5α SPRY/coiled-coil interactions optimize avid retroviral capsid recognition.
Autor: Marcin D Roganowicz, a další
Vydáno: (2017-10-01) -
Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
Autor: Mallori Burse, a další
Vydáno: (2017-01-01) -
TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
Autor: Molly Ohainle, a další
Vydáno: (2020-04-01) -
Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
Autor: Gongpu Zhao, a další
Vydáno: (2011-03-01) -
Targeting TRIM5 alpha in HIV cure strategies for the CRISPR-Cas9 era
Autor: Weatherley, D, a další
Vydáno: (2017)